Improving success of novel therapeutics for cognitive aspects of psychiatric disease: a bridge too far?
Expert Rev Clin Pharmacol
.
2012 Nov;5(6):601-3.
doi: 10.1586/ecp.12.63.
Authors
Francois Gastambide
,
Gary Gilmour
PMID:
23234318
DOI:
10.1586/ecp.12.63
No abstract available
Publication types
Editorial
MeSH terms
Animals
Cognition / drug effects*
Cognition Disorders / diagnosis
Cognition Disorders / drug therapy*
Drug Discovery
Humans
Models, Animal
Treatment Outcome